Lesaffre finalized the acquisition of dsm-firmenich’s yeast extract business today, October 2. Lesaffre’s Business Unit Biospringer, specializing in natural origin solutions from yeast fermentation, will integrate dsm-firmenich’s yeast derivatives processing technologies and products. The team of 46 dsm-firmenich employees working on yeast extracts will also join Lesaffre.

The integration process will begin immediately, Lesaffre announces. Both companies are working together to ensure a smooth transition for employees, customers, and partners.

dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam.

Photo: Pexels